Neurontin Whistleblower Alleges Sham Research Arrangements, Atty. Says

The whistleblower suit against Parke-Davis includes allegations that the company ran sham research programs to encourage use of its products, Sidley Austin Brown & Wood partner Scott Bass told a recent Drug Information Association meeting on marketing and compliance in New York City

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet